Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices
Market Cap
$15.45 Million
Skr173.29 Million SEK
Market Cap Rank
#27131 Global
#360 in Sweden
Share Price
Skr5.56
Change (1 day)
+3.54%
52-Week Range
Skr2.55 - Skr11.82
All Time High
Skr1089.26
About

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more

Clinical Laserthermia Systems AB (publ) - Asset Resilience Ratio

Latest as of June 2023: 0.31%

Clinical Laserthermia Systems AB (publ) (CLS-B) has an Asset Resilience Ratio of 0.31% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
Skr139.00K
Cash + Short-term Investments
Total Assets
Skr44.47 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2022)

This chart shows how Clinical Laserthermia Systems AB (publ)'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Clinical Laserthermia Systems AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr139.00K 0.31%
Total Liquid Assets Skr139.00K 0.31%

Asset Resilience Insights

  • Limited Liquidity: Clinical Laserthermia Systems AB (publ) maintains only 0.31% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Clinical Laserthermia Systems AB (publ) Industry Peers by Asset Resilience Ratio

Compare Clinical Laserthermia Systems AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Clinical Laserthermia Systems AB (publ) (2017–2022)

The table below shows the annual Asset Resilience Ratio data for Clinical Laserthermia Systems AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.28% Skr139.49K Skr49.51 Million -43.86pp
2021-12-31 44.14% Skr29.46 Million Skr66.74 Million +18.74pp
2020-12-31 25.40% Skr11.28 Million Skr44.40 Million +16.07pp
2019-12-31 9.32% Skr3.60 Million Skr38.67 Million -31.96pp
2018-12-31 41.28% Skr23.95 Million Skr58.02 Million +10.97pp
2017-12-31 30.31% Skr13.62 Million Skr44.94 Million --
pp = percentage points